| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |